Aurinia Pharmaceuticals Inc (AUPH) vs Recursion Pharmaceuticals, Inc. (RXRX)

Aurinia Pharmaceuticals Inc and Recursion Pharmaceuticals, Inc. are both Biotechnology companies. Aurinia Pharmaceuticals Inc and Recursion Pharmaceuticals, Inc. are of similar size ($2.2B and $2.1B). Recursion Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Aurinia Pharmaceuticals Inc trades at 6.9×. Aurinia Pharmaceuticals Inc grew revenue faster over the last twelve months: 19.8% against −15.1%. Aurinia Pharmaceuticals Inc has the higher net margin (100.8% vs −945.9%) and the higher return on invested capital (40.8% vs −92.2%). Across the 18 metrics below, Aurinia Pharmaceuticals Inc leads on 15 and Recursion Pharmaceuticals, Inc. on 3.